NO20052125L - Utvortes preparat for inhibering av keloiddannelse - Google Patents

Utvortes preparat for inhibering av keloiddannelse

Info

Publication number
NO20052125L
NO20052125L NO20052125A NO20052125A NO20052125L NO 20052125 L NO20052125 L NO 20052125L NO 20052125 A NO20052125 A NO 20052125A NO 20052125 A NO20052125 A NO 20052125A NO 20052125 L NO20052125 L NO 20052125L
Authority
NO
Norway
Prior art keywords
inhibition
external preparation
keloid formation
keloid
effect
Prior art date
Application number
NO20052125A
Other languages
English (en)
Other versions
NO20052125D0 (no
NO335116B1 (no
Inventor
Mitsuhiro Kawada
Yukiko Inamoto
Takeshi Kawazoe
Shigehiko Suzuki
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of NO20052125D0 publication Critical patent/NO20052125D0/no
Publication of NO20052125L publication Critical patent/NO20052125L/no
Publication of NO335116B1 publication Critical patent/NO335116B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Abstract

Et utvortes preparat som inneholder acetylsalisylsyre eller et salt av denne som en aktiv ingrediens og som har virkning på inhibering av keloid og/eller hypertrofisk arrdannelse samt analgetisk og kløestillende virkning.
NO20052125A 2002-09-30 2005-04-29 Utvortes preparat som inneholder acetylsalisylsyre for inhibering av keloiddannelse og dets anvendelse for fremstilling av et utvortes medikament NO335116B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002285650A JP4868687B2 (ja) 2002-09-30 2002-09-30 ケロイド等の形成抑制外用剤
PCT/JP2003/010728 WO2004030676A1 (ja) 2002-09-30 2003-08-26 ケロイド等の形成抑制外用剤

Publications (3)

Publication Number Publication Date
NO20052125D0 NO20052125D0 (no) 2005-04-29
NO20052125L true NO20052125L (no) 2005-06-29
NO335116B1 NO335116B1 (no) 2014-09-15

Family

ID=32063562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052125A NO335116B1 (no) 2002-09-30 2005-04-29 Utvortes preparat som inneholder acetylsalisylsyre for inhibering av keloiddannelse og dets anvendelse for fremstilling av et utvortes medikament

Country Status (12)

Country Link
US (1) US20050239755A1 (no)
EP (1) EP1547602A4 (no)
JP (1) JP4868687B2 (no)
KR (1) KR101149985B1 (no)
CN (1) CN100364543C (no)
AU (1) AU2003257700B2 (no)
BR (1) BR0314944A (no)
CA (1) CA2499620C (no)
NO (1) NO335116B1 (no)
NZ (1) NZ539158A (no)
WO (1) WO2004030676A1 (no)
ZA (1) ZA200502356B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101210B2 (en) * 2007-10-25 2012-01-24 Neochemir Inc. Use of carbon dioxide supplying means for muscle strengthening and method of increasing cattle meat thereby
US8877185B2 (en) 2012-05-10 2014-11-04 Stan S. Sastry Managing and treating keloids
FR2999936B1 (fr) * 2012-12-21 2015-01-16 Urgo Lab Utilisation d'acide acetylsalicylique pour la prevention et/ou le traitement des plaies du diabetique
CN103432145A (zh) * 2013-07-01 2013-12-11 宁夏医科大学 一种治疗瘢痕的外用西药组合物制剂及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
JPS57128328A (en) * 1981-12-03 1982-08-09 Canon Inc Motordriven device for camera
US5487899A (en) * 1994-01-31 1996-01-30 Jess Clarke & Sons, Inc. Wound healing
JPH08208487A (ja) * 1995-02-01 1996-08-13 Sekisui Chem Co Ltd 炎症性皮膚疾患治療用外用剤
JPH08268886A (ja) * 1995-03-31 1996-10-15 Eisai Co Ltd 血管新生抑制剤
JP3979689B2 (ja) * 1995-12-26 2007-09-19 帝國製薬株式会社 アセチルサリチル酸含有皮膚損傷治療剤
ES2250983T3 (es) * 1995-12-26 2006-04-16 Teikoku Seiyaku Kabushiki Kaisha Utilizacion del acido acetilsalicilico en la fabricacion de un medicamento para el tratamiento de las lesiones de la piel.
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
HU228233B1 (en) * 1999-12-28 2013-02-28 Teikoku Seiyaku Co Antipruritic agents for external use
ES2290120T3 (es) * 2000-03-17 2008-02-16 Avocet Polymer Technologies, Inc. Procedimientos para mejorar la dimension y el aspecto de una herida.

Also Published As

Publication number Publication date
NO20052125D0 (no) 2005-04-29
JP4868687B2 (ja) 2012-02-01
JP2004123551A (ja) 2004-04-22
CA2499620C (en) 2011-02-15
BR0314944A (pt) 2005-08-02
KR20050063771A (ko) 2005-06-28
US20050239755A1 (en) 2005-10-27
CN100364543C (zh) 2008-01-30
CN1684692A (zh) 2005-10-19
CA2499620A1 (en) 2004-04-15
EP1547602A4 (en) 2007-09-26
NZ539158A (en) 2008-09-26
WO2004030676A1 (ja) 2004-04-15
NO335116B1 (no) 2014-09-15
ZA200502356B (en) 2005-12-28
EP1547602A1 (en) 2005-06-29
AU2003257700A1 (en) 2004-04-23
AU2003257700B2 (en) 2009-04-30
KR101149985B1 (ko) 2012-06-01

Similar Documents

Publication Publication Date Title
BRPI0502466A (pt) forma de dosagem sólida para ingrediente ativo lábil a ácidos
NO20034627D0 (no) Oralt avleverbart farmasöytisk preparat innbefattende en aktiv forbindelsemed en aminosulfonylgruppe (cox-2 inhibitor) en polyetylenglykolog et friradikal-fjernende antioksidasjonsmiddel
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20065477L (no) Kombinasjoner omfattende antimuskarinmidler og PDE4-inhibitorer
BR0210971A (pt) Formas inovadoras de dosagem de benzimidazol substituìdo e método para usar as mesmas
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
NO20061818L (no) Fremgangsmate for a inhibere remnant lipoproteinproduksjon
WO2006087206A3 (en) Androgen receptor-dependent gene expression control by inhibiting the amine oxidase activity of lysine-specific demethylase (lsd1)
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
DE602005027540D1 (de) Feste formulierungen von ospemifen
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
NO20050060L (no) Medikament for behandling av overaktiv blaere
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
EP1704856A4 (en) PROTEIN INHIBITOR OF THE HSP90 FAMILY
HRP20080027T3 (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
NO20052125L (no) Utvortes preparat for inhibering av keloiddannelse
DK1678162T3 (da) P-glycoprotein-inhibitor, fremgangsmåde til fremstilling heraf og farmaceutisk sammensætning omfattende denne
MA27669A1 (fr) Formulations topiques stabilisees contenant du ketoprofene
NO20061088L (no) Protonpumpe inhibitor formuleringer og fremgangsmater for fremstilling og anvendelse av slike formuleringer
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
AR057885A1 (es) Acido 1-(1-(2- etoxietil) - 1- etil-7-(4- metilpiridin -2- ilamino)- 1h pirazolo (4,3-d) pirimidin -5- il) piperidina -4- carboxilico y las sales del mismo. composiciones farmaceuticas.
ITMI20032019A1 (it) Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
NO20063626L (no) Topisk anvendt medikament for dyr
NO20023111L (no) Utvortes preparat for behandling av pruritus

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees